Literature DB >> 25797428

In reply.

Thomas Seufferlein.   

Abstract

Mesh:

Year:  2015        PMID: 25797428      PMCID: PMC4335495          DOI: 10.3238/arztebl.2015.0060b

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

1.  [S3-guideline exocrine pancreatic cancer].

Authors:  T Seufferlein; M Porzner; T Becker; V Budach; G Ceyhan; I Esposito; R Fietkau; M Follmann; H Friess; P Galle; M Geissler; M Glanemann; T Gress; V Heinemann; W Hohenberger; U Hopt; J Izbicki; E Klar; J Kleeff; I Kopp; F Kullmann; T Langer; J Langrehr; M Lerch; M Löhr; J Lüttges; M Lutz; J Mayerle; P Michl; P Möller; M Molls; M Münter; M Nothacker; H Oettle; S Post; A Reinacher-Schick; C Röcken; E Roeb; H Saeger; R Schmid; W Schmiegel; M Schoenberg; J Siveke; M Stuschke; A Tannapfel; W Uhl; S Unverzagt; B van Oorschot; Y Vashist; J Werner; E Yekebas
Journal:  Z Gastroenterol       Date:  2013-12-11       Impact factor: 2.000

Review 2.  Ductal pancreatic adenocarcinoma.

Authors:  Thomas Seufferlein; Marc Porzner; Volker Heinemann; Andrea Tannapfel; Martin Stuschke; Waldemar Uhl
Journal:  Dtsch Arztebl Int       Date:  2014-05-30       Impact factor: 5.594

3.  Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer.

Authors:  Atsushi Sofuni; Fuminori Moriyasu; Takatomo Sano; Fumihide Itokawa; Takayoshi Tsuchiya; Toshio Kurihara; Kentaro Ishii; Syujiro Tsuji; Nobuhito Ikeuchi; Reina Tanaka; Junko Umeda; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Mitsuru Fujita; Takao Itoi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.